Long-term survival in a patient with chronic myelogenous leukemia without any treatment

Abstract

Chronic myelogenous leukemia (CML) is a myeloproliferative disease with a well known course. With chemotherapy, average survival of these patients is 3-5 years. All of the long term survivors of CML have been treated patients. Here we are reporting on a long term survivor (more than 10 years) without treatment.